Arbutus Biopharma (ABUS) Short Interest Ratio & Short Volume → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free ABUS Stock Alerts $2.75 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Arbutus Biopharma Short Interest DataCurrent Short Volume4,550,000 sharesPrevious Short Volume4,130,000 sharesChange Vs. Previous Month+10.17%Dollar Volume Sold Short$11.74 millionShort Interest Ratio / Days to Cover3.4Last Record DateMarch 31, 2024Outstanding Shares179,490,000 sharesPercentage of Shares Shorted2.53%Today's Trading Volume344,844 sharesAverage Trading Volume1,265,202 sharesToday's Volume Vs. Average27% Short Selling Arbutus Biopharma ? Sign up to receive the latest short interest report for Arbutus Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABUS Short Interest Over TimeABUS Days to Cover Over TimeABUS Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Arbutus Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20244,550,000 shares $11.74 million +10.2%N/A3.4 $2.58 3/15/20244,130,000 shares $10.82 million +1.5%N/A4.4 $2.62 2/29/20244,070,000 shares $11.40 million +10.3%N/A4.2 $2.80 2/15/20243,690,000 shares $10.74 million -39.7%N/A3.8 $2.91 1/31/20246,120,000 shares $14.50 million -4.8%N/A7.3 $2.37 1/15/20246,430,000 shares $14.85 million +3.4%N/A9.5 $2.31 Get the Latest News and Ratings for ABUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/20236,220,000 shares $15.55 million +0.5%N/A9.1 $2.50 12/15/20236,190,000 shares $13.87 million +0.2%N/A9.2 $2.24 11/30/20236,180,000 shares $12.67 million -8.2%N/A9.4 $2.05 11/15/20236,730,000 shares $12.38 million +6.7%N/A10.6 $1.84 10/31/20236,310,000 shares $11.55 million +9.4%N/A10.4 $1.83 10/15/20235,770,000 shares $10.73 million -16.1%N/A9.4 $1.86 9/30/20236,880,000 shares $13.97 million +18.6%N/A11.2 $2.03 9/15/20235,800,000 shares $11.83 million +12.0%N/A9.4 $2.04 8/31/20235,180,000 shares $10.52 million +0.8%N/A8.3 $2.03 8/15/20235,140,000 shares $10.23 million +5.1%N/A8.4 $1.99 7/31/20234,890,000 shares $10.61 million +0.8%N/A8.5 $2.17 7/15/20234,850,000 shares $10.82 million -0.8%N/A7.8 $2.23 6/30/20234,890,000 shares $11.25 million +12.7%N/A6.8 $2.30 6/15/20234,340,000 shares $10.59 million +2.1%N/A5.8 $2.44 5/31/20234,250,000 shares $10.58 million -0.9%N/A5.3 $2.49 5/15/20234,290,000 shares $10.98 million +8.3%N/A4.7 $2.56 4/30/20233,960,000 shares $9.94 million -7.0%N/A4.2 $2.51 4/15/20234,260,000 shares $12.23 million -13.9%N/A4.7 $2.87 3/31/20234,950,000 shares $15.00 million +5.5%N/A5.4 $3.03 3/15/20234,690,000 shares $14.21 million +15.8%N/A5 $3.03 2/28/20234,050,000 shares $11.26 million +1.5%N/A4.5 $2.78 2/15/20233,990,000 shares $10.85 million -7.4%N/A4.5 $2.72 1/31/20234,310,000 shares $12.97 million -8.5%N/A4.6 $3.01 1/15/20234,710,000 shares $13.42 million -0.6%N/A4.9 $2.85 12/30/20224,740,000 shares $11.04 million +23.1%N/A4.6 $2.33 12/15/20223,850,000 shares $10.43 million -4.0%N/A4.1 $2.71 11/30/20224,010,000 shares $9.42 million +7.2%N/A4.4 $2.35 11/15/20223,740,000 shares $10.43 million -10.3%N/A4.3 $2.79 10/31/20224,170,000 shares $9.76 million -0.7%N/A5.2 $2.34 10/15/20224,200,000 shares $9.20 million +2.2%N/A5.4 $2.19 9/30/20224,110,000 shares $7.85 million +7.6%N/A5.6 $1.91 9/15/20223,820,000 shares $8.82 million -2.6%N/A4.7 $2.31 8/31/20223,920,000 shares $8.70 million -11.1%N/A4.7 $2.22 8/15/20224,410,000 shares $11.16 million -7.4%N/A4.8 $2.53Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report ABUS Short Interest - Frequently Asked Questions What is Arbutus Biopharma's current short interest? Short interest is the volume of Arbutus Biopharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 4,550,000 shares of ABUS short. Learn More on Arbutus Biopharma's current short interest. What is a good short interest ratio for Arbutus Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABUS shares currently have a short interest ratio of 3.0. Learn More on Arbutus Biopharma's short interest ratio. Which institutional investors are shorting Arbutus Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arbutus Biopharma: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Arbutus Biopharma's short interest increasing or decreasing? Arbutus Biopharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 4,550,000 shares, an increase of 10.2% from the previous total of 4,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Arbutus Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Arbutus Biopharma: Oculis Holding AG (0.17%), COMPASS Pathways plc (5.05%), AnaptysBio, Inc. (18.16%), KalVista Pharmaceuticals, Inc. (13.08%), Applied Therapeutics, Inc. (4.70%), Stoke Therapeutics, Inc. (15.01%), Fulcrum Therapeutics, Inc. (3.64%), Adlai Nortye Ltd. (0.02%), Astria Therapeutics, Inc. (11.37%), Phathom Pharmaceuticals, Inc. (39.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Arbutus Biopharma stock? Short selling ABUS is an investing strategy that aims to generate trading profit from Arbutus Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arbutus Biopharma? A short squeeze for Arbutus Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABUS, which in turn drives the price of the stock up even further. How often is Arbutus Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABUS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: OCS Short Squeeze CMPS Short Squeeze ANAB Short Squeeze KALV Short Squeeze APLT Short Squeeze STOK Short Squeeze FULC Short Squeeze ANL Short Squeeze ATXS Short Squeeze PHAT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABUS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing